vs
Side-by-side financial comparison of Barnes & Noble Education, Inc. (BNED) and Hologic (HOLX). Click either name above to swap in a different company.
Hologic is the larger business by last-quarter revenue ($1.0B vs $598.2M, roughly 1.8× Barnes & Noble Education, Inc.). Hologic runs the higher net margin — 17.1% vs 4.2%, a 12.9% gap on every dollar of revenue. On growth, Barnes & Noble Education, Inc. posted the faster year-over-year revenue change (6.9% vs 2.5%). Hologic produced more free cash flow last quarter ($215.2M vs $61.9M). Over the past eight quarters, Barnes & Noble Education, Inc.'s revenue compounded faster (20.0% CAGR vs 1.5%).
Barnes & Noble Booksellers is an American bookseller with the largest number of retail outlets in the United States. The company operates approximately 700+ retail stores across the United States.
Hologic, Inc. is an American medical technology company primarily focused on women's health; it sells medical devices for diagnostics, surgery, and medical imaging.
BNED vs HOLX — Head-to-Head
Income Statement — Q2 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $598.2M | $1.0B |
| Net Profit | $25.0M | $179.1M |
| Gross Margin | 21.7% | 56.0% |
| Operating Margin | 6.8% | 22.6% |
| Net Margin | 4.2% | 17.1% |
| Revenue YoY | 6.9% | 2.5% |
| Net Profit YoY | -49.7% | -10.9% |
| EPS (diluted) | $0.72 | $0.79 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $598.2M | $1.0B | ||
| Q3 25 | $274.2M | $1.0B | ||
| Q2 25 | $233.0M | $1.0B | ||
| Q1 25 | $419.7M | $1.0B | ||
| Q4 24 | $559.7M | $1.0B | ||
| Q3 24 | $250.9M | $988.0M | ||
| Q2 24 | $192.7M | $1.0B | ||
| Q1 24 | $415.4M | $1.0B |
| Q4 25 | $25.0M | $179.1M | ||
| Q3 25 | $-18.3M | $187.2M | ||
| Q2 25 | $-23.0M | $194.9M | ||
| Q1 25 | $17.9M | $-17.4M | ||
| Q4 24 | $43.2M | $201.0M | ||
| Q3 24 | $-103.9M | $178.6M | ||
| Q2 24 | $-41.9M | $194.5M | ||
| Q1 24 | $-9.3M | $169.9M |
| Q4 25 | 21.7% | 56.0% | ||
| Q3 25 | 20.2% | 55.6% | ||
| Q2 25 | 30.3% | 56.3% | ||
| Q1 25 | 22.3% | 37.5% | ||
| Q4 24 | 23.0% | 56.8% | ||
| Q3 24 | 17.9% | 56.4% | ||
| Q2 24 | 28.7% | 55.4% | ||
| Q1 24 | 24.2% | 53.3% |
| Q4 25 | 6.8% | 22.6% | ||
| Q3 25 | -8.4% | 22.6% | ||
| Q2 25 | -4.9% | 24.9% | ||
| Q1 25 | 4.5% | -0.7% | ||
| Q4 24 | 8.4% | 22.5% | ||
| Q3 24 | -15.4% | 23.3% | ||
| Q2 24 | -16.3% | 24.1% | ||
| Q1 24 | 0.4% | 20.7% |
| Q4 25 | 4.2% | 17.1% | ||
| Q3 25 | -6.7% | 17.8% | ||
| Q2 25 | -9.9% | 19.0% | ||
| Q1 25 | 4.3% | -1.7% | ||
| Q4 24 | 7.7% | 19.7% | ||
| Q3 24 | -41.4% | 18.1% | ||
| Q2 24 | -21.7% | 19.2% | ||
| Q1 24 | -2.2% | 16.7% |
| Q4 25 | $0.72 | $0.79 | ||
| Q3 25 | $-0.54 | $0.84 | ||
| Q2 25 | $2.97 | $0.86 | ||
| Q1 25 | $0.59 | $-0.08 | ||
| Q4 24 | $1.63 | $0.87 | ||
| Q3 24 | $-7.69 | $0.75 | ||
| Q2 24 | $-15.68 | $0.82 | ||
| Q1 24 | $-3.49 | $0.72 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $11.7M | $2.4B |
| Total DebtLower is stronger | $122.5M | $2.5B |
| Stockholders' EquityBook value | $283.2M | $5.2B |
| Total Assets | $1.1B | $9.2B |
| Debt / EquityLower = less leverage | 0.43× | 0.48× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.7M | $2.4B | ||
| Q3 25 | $7.3M | $2.2B | ||
| Q2 25 | $9.1M | $1.9B | ||
| Q1 25 | $9.2M | $1.6B | ||
| Q4 24 | $11.6M | $2.0B | ||
| Q3 24 | $8.2M | $2.3B | ||
| Q2 24 | $10.5M | $2.4B | ||
| Q1 24 | $8.1M | $2.2B |
| Q4 25 | $122.5M | $2.5B | ||
| Q3 25 | $170.0M | $2.5B | ||
| Q2 25 | $103.1M | $2.5B | ||
| Q1 25 | $141.2M | $2.5B | ||
| Q4 24 | $177.6M | $2.5B | ||
| Q3 24 | $221.9M | $2.5B | ||
| Q2 24 | $196.3M | $2.5B | ||
| Q1 24 | $30.2M | $2.6B |
| Q4 25 | $283.2M | $5.2B | ||
| Q3 25 | $256.5M | $5.0B | ||
| Q2 25 | $272.2M | $4.8B | ||
| Q1 25 | $292.9M | $4.6B | ||
| Q4 24 | $211.4M | $4.8B | ||
| Q3 24 | $149.8M | $5.1B | ||
| Q2 24 | $80.4M | $5.0B | ||
| Q1 24 | $121.5M | $4.8B |
| Q4 25 | $1.1B | $9.2B | ||
| Q3 25 | $950.8M | $9.0B | ||
| Q2 25 | $790.3M | $8.8B | ||
| Q1 25 | $1.1B | $8.5B | ||
| Q4 24 | $1.0B | $8.7B | ||
| Q3 24 | $973.2M | $9.2B | ||
| Q2 24 | $909.9M | $8.9B | ||
| Q1 24 | $1.2B | $8.7B |
| Q4 25 | 0.43× | 0.48× | ||
| Q3 25 | 0.66× | 0.50× | ||
| Q2 25 | 0.38× | 0.52× | ||
| Q1 25 | 0.48× | 0.55× | ||
| Q4 24 | 0.84× | 0.53× | ||
| Q3 24 | 1.48× | 0.49× | ||
| Q2 24 | 2.44× | 0.51× | ||
| Q1 24 | 0.25× | 0.53× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $66.2M | $229.9M |
| Free Cash FlowOCF − Capex | $61.9M | $215.2M |
| FCF MarginFCF / Revenue | 10.4% | 20.5% |
| Capex IntensityCapex / Revenue | 0.7% | 1.4% |
| Cash ConversionOCF / Net Profit | 2.65× | 1.28× |
| TTM Free Cash FlowTrailing 4 quarters | $-4.6M | $1.0B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $66.2M | $229.9M | ||
| Q3 25 | $-67.6M | $355.1M | ||
| Q2 25 | $52.6M | $343.3M | ||
| Q1 25 | $-41.9M | $169.4M | ||
| Q4 24 | $47.4M | $189.3M | ||
| Q3 24 | $-143.5M | $367.0M | ||
| Q2 24 | $81.7M | $405.8M | ||
| Q1 24 | $-35.8M | $292.4M |
| Q4 25 | $61.9M | $215.2M | ||
| Q3 25 | $-71.3M | $341.4M | ||
| Q2 25 | $49.5M | $330.5M | ||
| Q1 25 | $-44.7M | $153.9M | ||
| Q4 24 | $44.4M | $172.5M | ||
| Q3 24 | $-147.5M | $350.6M | ||
| Q2 24 | $79.1M | $385.3M | ||
| Q1 24 | $-39.0M | $279.6M |
| Q4 25 | 10.4% | 20.5% | ||
| Q3 25 | -26.0% | 32.5% | ||
| Q2 25 | 21.3% | 32.3% | ||
| Q1 25 | -10.7% | 15.3% | ||
| Q4 24 | 7.9% | 16.9% | ||
| Q3 24 | -58.8% | 35.5% | ||
| Q2 24 | 41.1% | 38.1% | ||
| Q1 24 | -9.4% | 27.5% |
| Q4 25 | 0.7% | 1.4% | ||
| Q3 25 | 1.4% | 1.3% | ||
| Q2 25 | 1.3% | 1.3% | ||
| Q1 25 | 0.7% | 1.5% | ||
| Q4 24 | 0.5% | 1.6% | ||
| Q3 24 | 1.6% | 1.7% | ||
| Q2 24 | 1.4% | 2.0% | ||
| Q1 24 | 0.8% | 1.3% |
| Q4 25 | 2.65× | 1.28× | ||
| Q3 25 | — | 1.90× | ||
| Q2 25 | — | 1.76× | ||
| Q1 25 | -2.34× | — | ||
| Q4 24 | 1.10× | 0.94× | ||
| Q3 24 | — | 2.05× | ||
| Q2 24 | — | 2.09× | ||
| Q1 24 | — | 1.72× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BNED
| Course Materials Product | $459.3M | 77% |
| General Merchandise Product | $112.9M | 19% |
| Serviceand Other | $26.1M | 4% |
HOLX
| Molecular Diagnostics | $255.3M | 24% |
| Breast Imaging | $219.9M | 21% |
| Services | $216.4M | 21% |
| Capital Equipment Componentsand Software | $187.2M | 18% |
| Cytology Perinatal | $76.0M | 7% |
| Interventional Breast Solutions | $71.2M | 7% |
| Blood Screening | $8.4M | 1% |
| Other Typeof Revenue | $5.4M | 1% |
